2
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
6397
Neoplasms
5369
Prostatic Neoplasms
2966
Carcinoma, Non-Small-Cell Lung
2709
Colorectal Neoplasms
2679
Lung Neoplasms
2269
Multiple Myeloma
1663
Lymphoma
1600
Neoplasm Metastasis
1554
Leukemia, Myeloid, Acute
1540
Melanoma
1486
Pancreatic Neoplasms
1470
Ovarian Neoplasms
1424
Leukemia
1389
Head and Neck Neoplasms
1284
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1283
Lymphoma, Non-Hodgkin
1231
Colonic Neoplasms
1160
Carcinoma, Hepatocellular
1142
Stomach Neoplasms
1130
Leukemia, Lymphocytic, Chronic, B-Cell
1090
Brain Neoplasms
1053
Rectal Neoplasms
980
Lymphoma, Follicular
979
Recurrence
978
Uterine Cervical Neoplasms
927
Glioblastoma
921
Carcinoma, Renal Cell
883
Lymphoma, Large B-Cell, Diffuse
854
Hodgkin Disease
777
Interventions
abiraterone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
×
Clear all
NCT01780220
2022-05-19
CARLHA
UNICANCER
Phase 1/2
Completed
47 enrolled